Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma

MLA

Brown, Christine E., et al. “Off-the-Shelf, Steroid-Resistant, IL13Rα2-Specific CAR T Cells for Treatment of Glioblastoma.” Neuro-Oncology, vol. 24, Jan. 2022, pp. 1318–30. EBSCOhost, https://doi.org/10.1093/neuonc/noac024.

APA

Brown, C. E., Rodriguez, A., Palmer, J., Ostberg, J. R., Naranjo, A., Wagner, J. R., Aguilar, B., Starr, R., Weng, L., Synold, T. W., Tran, V., Wang, S., Reik, A., D, A. M., Ressler, J. A., Zhou, Y., Mendel, M., Gregory, P. D., Holmes, M. C., … Badie, B. (2022). Off-the-shelf, steroid-resistant, IL13Rα2-specific CAR T cells for treatment of glioblastoma. Neuro-Oncology, 24, 1318–1330. https://doi.org/10.1093/neuonc/noac024

Chicago

Brown, Christine E, Analiz Rodriguez, Joycelynne Palmer, Julie R Ostberg, Araceli Naranjo, Jamie R Wagner, Brenda Aguilar, et al. 2022. “Off-the-Shelf, Steroid-Resistant, IL13Rα2-Specific CAR T Cells for Treatment of Glioblastoma.” Neuro-Oncology 24 (January): 1318–30. doi:10.1093/neuonc/noac024.